1. Home
  2. CASI
  3. CASI News

Latest CASI Pharmaceuticals Inc. (CASI) News on September 16, 2025

CASI

ACCESS Newswire

8 days ago

CASI Pharmaceuticals Announces Safety Monitoring Committee Recommendation to Escalate CID-103 Dose to Next Cohort in Phase 1 Immune Thrombocytopenia (ITP) Study

CASI

ACCESS Newswire

4 months ago

CASI Pharmaceuticals Provides Business and Clinical Update

CASI

ACCESS Newswire

4 months ago

CASI Pharmaceuticals Announces First Quarter 2025 Business and Financial Results

CASI

MT Newswires

4 months ago

CASI to Divest Two Subsidiaries in China

CASI

ACCESS Newswire

4 months ago

CASI Pharmaceuticals Enters Into Definitive Agreement for the Divestiture of Assets in China

CASI

ACCESS Newswire

4 months ago

CASI Pharmaceuticals Receives Nasdaq Deficiency Notice Regarding Minimum Market Value Requirement

CASI

ACCESS Newswire

5 months ago

CASI Pharmaceuticals Announces Receipt of An Updated Non-Binding Proposal to Acquire Entire China Business of the Company

CASI Pharmaceuticals Full Year 2024 Earnings: US$2.56 loss per share (vs US$2.02 loss in FY 2023)
CASI

Simply Wall St.

5 months ago

CASI Pharmaceuticals Full Year 2024 Earnings: US$2.56 loss per share (vs US$2.02 loss in FY 2023)

CASI

ACCESS Newswire

6 months ago

CASI Pharmaceuticals Announces Fourth Quarter and Full-Year 2024 Business and Financial Results

This CASI Pharmaceuticals Insider Increased Their Holding By 65% Last Year
CASI

Simply Wall St.

7 months ago

This CASI Pharmaceuticals Insider Increased Their Holding By 65% Last Year

CASI

ACCESSWIRE

8 months ago

CASI Announces First Patient Dosed in Phase 1/2 Clinical Trial of CID-103 in Immune Thrombocytopenia

CASI Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations
CASI

Simply Wall St.

10 months ago

CASI Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations

CASI

ACCESSWIRE

10 months ago

CASI Pharmaceuticals Announces Third Quarter 2024 Business and Financial Results

CASI Pharmaceuticals Inc (CASI) Q3 2024 Earnings Report Preview: What To Expect
CASI

GuruFocus.com

10 months ago

CASI Pharmaceuticals Inc (CASI) Q3 2024 Earnings Report Preview: What To Expect

CASI

MT Newswires

a year ago

Casi Pharmaceuticals Says China Cleared Phase 1/2 Trial in Immune Thrombocytopenia

CASI

ACCESSWIRE

a year ago

CASI Pharmaceuticals Receives CTA Approval From China's NMPA for CID-103 in Immune Thrombocytopenia

CASI Pharmaceuticals (NASDAQ:CASI) shareholders are still up 129% over 1 year despite pulling back 22% in the past week
CASI

Simply Wall St.

a year ago

CASI Pharmaceuticals (NASDAQ:CASI) shareholders are still up 129% over 1 year despite pulling back 22% in the past week

CASI PHARMACEUTICALS TO PARTICIPATE IN THE 2024 H.C. WAINWRIGHT GLOBAL INVESTMENT CONFERENCE
CASI

PR Newswire

a year ago

CASI PHARMACEUTICALS TO PARTICIPATE IN THE 2024 H.C. WAINWRIGHT GLOBAL INVESTMENT CONFERENCE

CASI PHARMACEUTICALS ANNOUNCES SECOND QUARTER 2024 BUSINESS AND FINANCIAL RESULTS
CASI

PR Newswire

a year ago

CASI PHARMACEUTICALS ANNOUNCES SECOND QUARTER 2024 BUSINESS AND FINANCIAL RESULTS

CASI PHARMACEUTICALS REPORTS DEVELOPMENT RELATING TO ITS DISPUTES WITH JUVENTAS
CASI

PR Newswire

a year ago

CASI PHARMACEUTICALS REPORTS DEVELOPMENT RELATING TO ITS DISPUTES WITH JUVENTAS

CASI

MT Newswires

a year ago

CASI Pharmaceuticals Names Daniel Lang CFO

CASI Pharmaceuticals announces appointment of Daniel Lang, MD as CFO and SVP
CASI

PR Newswire

a year ago

CASI Pharmaceuticals announces appointment of Daniel Lang, MD as CFO and SVP

CASI Pharmaceuticals (CASI) Up on Buyout Offer for China Business
CASI

Zacks

a year ago

CASI Pharmaceuticals (CASI) Up on Buyout Offer for China Business

CASI

MT Newswires

a year ago

Top Premarket Gainers

CASI Pharmaceuticals Announces Plan To Submit IND Application For CID-103, an Anti-CD 38 Antibody in Antibody-Mediated Rejection, and Receipt of a Non-Binding Proposal to Acquire Entire China Business of the Company
CASI

PR Newswire

a year ago

CASI Pharmaceuticals Announces Plan To Submit IND Application For CID-103, an Anti-CD 38 Antibody in Antibody-Mediated Rejection, and Receipt of a Non-Binding Proposal to Acquire Entire China Business of the Company

CASI Pharmaceuticals Announces $15 Million Private Placement Financing by Venrock Healthcare Capital Partners, Foresite Capital, Panacea Venture and Dr. Wei-Wu He
CASI

PR Newswire

a year ago

CASI Pharmaceuticals Announces $15 Million Private Placement Financing by Venrock Healthcare Capital Partners, Foresite Capital, Panacea Venture and Dr. Wei-Wu He

CASI

MT Newswires

a year ago

CASI Pharmaceuticals Gets FDA Clearance For Blood Disorder Study

CASI Pharmaceuticals Receives FDA Clearance On The Investigational New Drug (IND) Application For CID-103 In Immune Thrombocytopenia (ITP)
CASI

PR Newswire

a year ago

CASI Pharmaceuticals Receives FDA Clearance On The Investigational New Drug (IND) Application For CID-103 In Immune Thrombocytopenia (ITP)

CASI PHARMACEUTICALS ANNOUNCES FIRST QUARTER 2024 BUSINESS AND FINANCIAL RESULTS
CASI

PR Newswire

a year ago

CASI PHARMACEUTICALS ANNOUNCES FIRST QUARTER 2024 BUSINESS AND FINANCIAL RESULTS

Analysts Are Optimistic We'll See A Profit From CASI Pharmaceuticals, Inc. (NASDAQ:CASI)
CASI

Simply Wall St.

a year ago

Analysts Are Optimistic We'll See A Profit From CASI Pharmaceuticals, Inc. (NASDAQ:CASI)

CASI PHARMACEUTICALS REPORTS DEVELOPMENT RELATING TO ITS DISPUTES WITH JUVENTAS
CASI

PR Newswire

a year ago

CASI PHARMACEUTICALS REPORTS DEVELOPMENT RELATING TO ITS DISPUTES WITH JUVENTAS

CASI PHARMACEUTICALS ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2023 BUSINESS AND FINANCIAL RESULTS
CASI

PR Newswire

a year ago

CASI PHARMACEUTICALS ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2023 BUSINESS AND FINANCIAL RESULTS

CASI Pharmaceuticals Report Positive Interim Phase 1 Data For BI-1206 In The Treatment Of Relapsed/Refractory Indolent Non-Hodgkin's Lymphoma In China
CASI

PR Newswire

2 years ago

CASI Pharmaceuticals Report Positive Interim Phase 1 Data For BI-1206 In The Treatment Of Relapsed/Refractory Indolent Non-Hodgkin's Lymphoma In China

CASI PHARMACEUTICALS ANNOUNCES FIRST DOSING OF FOLOTYN® IN CHINA
CASI

PR Newswire

2 years ago

CASI PHARMACEUTICALS ANNOUNCES FIRST DOSING OF FOLOTYN® IN CHINA

P3 Health Partners to Participate in The 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
CASI

Business Wire

2 years ago

P3 Health Partners to Participate in The 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

Franklin Financial Services (NASDAQ:FRAF) Will Pay A Dividend Of $0.32
CASI

Simply Wall St.

2 years ago

Franklin Financial Services (NASDAQ:FRAF) Will Pay A Dividend Of $0.32

Hippo Completes Successful 2024 Reinsurance Renewals
CASI

PR Newswire

2 years ago

Hippo Completes Successful 2024 Reinsurance Renewals

UNIFI, Makers of REPREVE®, Schedules Second Quarter Fiscal 2024 Earnings Conference Call
CASI

Business Wire

2 years ago

UNIFI, Makers of REPREVE®, Schedules Second Quarter Fiscal 2024 Earnings Conference Call

CASI

GuruFocus.com

2 years ago

Peoples Bancorp Inc. Reports Record Annual Earnings for 2023

Capricor Therapeutics Announces Collaboration with the National Institutes of Health for Clinical Trial of Novel Exosome-Based Multivalent Vaccine for SARS-CoV-2
CASI

GlobeNewswire

2 years ago

Capricor Therapeutics Announces Collaboration with the National Institutes of Health for Clinical Trial of Novel Exosome-Based Multivalent Vaccine for SARS-CoV-2

CASI

Thomson Reuters StreetEvents

2 years ago

Q4 2023 Peoples Bancorp Inc Earnings Call

Aquestive Therapeutics (AQST) Stock Slides as Market Rises: Facts to Know Before You Trade
CASI

Zacks

2 years ago

Aquestive Therapeutics (AQST) Stock Slides as Market Rises: Facts to Know Before You Trade

Here's What Key Metrics Tell Us About Peoples Bancorp (PEBO) Q4 Earnings
CASI

Zacks

2 years ago

Here's What Key Metrics Tell Us About Peoples Bancorp (PEBO) Q4 Earnings

7 Speculative Stocks to Double Your Money THIS Year
CASI

InvestorPlace

2 years ago

7 Speculative Stocks to Double Your Money THIS Year

Peoples Bancorp Announces Special Cash Dividend
CASI

GlobeNewswire

2 years ago

Peoples Bancorp Announces Special Cash Dividend

Cue Biopharma (NASDAQ:CUE) investors are sitting on a loss of 80% if they invested three years ago
CASI

Simply Wall St.

2 years ago

Cue Biopharma (NASDAQ:CUE) investors are sitting on a loss of 80% if they invested three years ago

Ceragon Anticipates Reaching the High-End of 2023 Revenue Guidance, Expects Double-Digit Growth and Targets Margin Expansion in 2024
CASI

PR Newswire

2 years ago

Ceragon Anticipates Reaching the High-End of 2023 Revenue Guidance, Expects Double-Digit Growth and Targets Margin Expansion in 2024

KNOT Offshore Partners LP Announces Fourth Quarter 2023 Cash Distribution
CASI

Business Wire

2 years ago

KNOT Offshore Partners LP Announces Fourth Quarter 2023 Cash Distribution

Nanox Mourns Death of Its Founder, Ran Poliakine
CASI

GlobeNewswire

2 years ago

Nanox Mourns Death of Its Founder, Ran Poliakine

3 Penny Stocks to Watch for Explosive Growth in Q1 2024
CASI

InvestorPlace

2 years ago

3 Penny Stocks to Watch for Explosive Growth in Q1 2024

Five Point Holdings, LLC Sets Date for Fourth Quarter and Year-end 2023 Earnings Announcement and Investor Conference Call
CASI

Business Wire

2 years ago

Five Point Holdings, LLC Sets Date for Fourth Quarter and Year-end 2023 Earnings Announcement and Investor Conference Call

Evolution (EPM) Expands Asset Base, Signs $43.5M Contract
CASI

Zacks

2 years ago

Evolution (EPM) Expands Asset Base, Signs $43.5M Contract

CASI

Business Wire

2 years ago

TiVo Launches TiVo Broadband for Operators Providing a Streaming Platform to Their Broadband Only Subscribers

CASI

Business Wire

2 years ago

DTS Play-Fi Demonstrates its Commitment to Advancing the Home Theater at CES 2024

CASI

Business Wire

2 years ago

Xperi Expands its Global Footprint with its Powered by TiVo Media Platform for Smart TVs and Connected Car

CASI

Business Wire

2 years ago

DTS AutoStage™ Expands into More Vehicle Models Following Video Launch, Developing New Functionality

Amundi US Declares Monthly Distributions for Pioneer Closed-End Funds
CASI

Business Wire

2 years ago

Amundi US Declares Monthly Distributions for Pioneer Closed-End Funds

The Honest Company Announces Appointment of Dorria L. Ball as Chief People Officer
CASI

GlobeNewswire

2 years ago

The Honest Company Announces Appointment of Dorria L. Ball as Chief People Officer

Solid Biosciences to Participate at 42nd Annual J.P. Morgan Healthcare Conference
CASI

GlobeNewswire

2 years ago

Solid Biosciences to Participate at 42nd Annual J.P. Morgan Healthcare Conference

INOVIO Plans to Submit a BLA for INO-3107 as a Potential Treatment for RRP in Second Half of 2024 Under Accelerated Approval Program
CASI

PR Newswire

2 years ago

INOVIO Plans to Submit a BLA for INO-3107 as a Potential Treatment for RRP in Second Half of 2024 Under Accelerated Approval Program

Five Point Holdings, LLC Announces Early Participation Deadline Results for the Previously Announced Exchange Offer and Consent Solicitation
CASI

Business Wire

2 years ago

Five Point Holdings, LLC Announces Early Participation Deadline Results for the Previously Announced Exchange Offer and Consent Solicitation

The Honest Company, Inc.'s (NASDAQ:HNST) Shares Leap 87% Yet They're Still Not Telling The Full Story
CASI

Simply Wall St.

2 years ago

The Honest Company, Inc.'s (NASDAQ:HNST) Shares Leap 87% Yet They're Still Not Telling The Full Story

Magnachip Commences Full-Scale Mass Production of New 30V MXT LV MOSFET for Electric Power Steering Systems
CASI

PR Newswire

2 years ago

Magnachip Commences Full-Scale Mass Production of New 30V MXT LV MOSFET for Electric Power Steering Systems

CASI Pharmaceuticals, Inc.'s (NASDAQ:CASI) Price Is Right But Growth Is Lacking After Shares Rocket 33%
CASI

Simply Wall St.

2 years ago

CASI Pharmaceuticals, Inc.'s (NASDAQ:CASI) Price Is Right But Growth Is Lacking After Shares Rocket 33%

Heritage Announces Launch of Primary Offering of Shares of Common Stock
CASI

PR Newswire

2 years ago

Heritage Announces Launch of Primary Offering of Shares of Common Stock

Life Science Investor Forum Agenda Announced for December 14th, 2023
CASI

GlobeNewswire

2 years ago

Life Science Investor Forum Agenda Announced for December 14th, 2023

While institutions invested in Solid Biosciences Inc. (NASDAQ:SLDB) benefited from last week's 68% gain, private equity firms stood to gain the most
CASI

Simply Wall St.

2 years ago

While institutions invested in Solid Biosciences Inc. (NASDAQ:SLDB) benefited from last week's 68% gain, private equity firms stood to gain the most

Heritage Insurance Holdings (NYSE:HRTG) shareholder returns have been fantastic, earning 421% in 1 year
CASI

Simply Wall St.

2 years ago

Heritage Insurance Holdings (NYSE:HRTG) shareholder returns have been fantastic, earning 421% in 1 year

Analysts Expect Breakeven For CASI Pharmaceuticals, Inc. (NASDAQ:CASI) Before Long
CASI

Simply Wall St.

2 years ago

Analysts Expect Breakeven For CASI Pharmaceuticals, Inc. (NASDAQ:CASI) Before Long

CASI

GuruFocus.com

2 years ago

Theseus Pharmaceuticals Inc (THRX) Explores Strategic Alternatives Amidst Workforce Reduction

CASI PHARMACEUTICALS ANNOUNCES THIRD QUARTER 2023 BUSINESS AND FINANCIAL UPDATES
CASI

PR Newswire

2 years ago

CASI PHARMACEUTICALS ANNOUNCES THIRD QUARTER 2023 BUSINESS AND FINANCIAL UPDATES

Perpetua Resources Announces Third Quarter 2023 Highlights
CASI

CNW Group

2 years ago

Perpetua Resources Announces Third Quarter 2023 Highlights

Inogen (INGN) Q3 Earnings Miss Estimates, Revenues Down Y/Y
CASI

Zacks

2 years ago

Inogen (INGN) Q3 Earnings Miss Estimates, Revenues Down Y/Y

CASI PHARMACEUTICALS ANNOUNCES MARKET APPROVAL OF CNCT19 BY CHINA NMPA
CASI

PR Newswire

2 years ago

CASI PHARMACEUTICALS ANNOUNCES MARKET APPROVAL OF CNCT19 BY CHINA NMPA

ARKO Corp Reports Decrease in Net Income and Adjusted EBITDA in Q3 2023
CASI

GuruFocus.com

2 years ago

ARKO Corp Reports Decrease in Net Income and Adjusted EBITDA in Q3 2023

SelectQuote Inc (SLQT) Reports Q1 2024 Earnings: Revenue Up by 43%, Net Loss Narrows
CASI

GuruFocus.com

2 years ago

SelectQuote Inc (SLQT) Reports Q1 2024 Earnings: Revenue Up by 43%, Net Loss Narrows

Share on Social Networks: